WASHINGTON, D.C. (SHNS)--The U.S. House voted unanimously Monday to reauthorize laws originally drafted by then-Rep. Ed Markey to assemble and execute on a coordinated strategic national plan to prevent and effectively treat Alzheimer’s disease, sending the updated versions to President Joe Biden's desk to become law. Markey founded and co-chairs the Congressional Task Force on Alzheimer's, and said the legislation awaiting the president's signature would "cement and build on the important progress that has been made to prevent and effectively treat Alzheimer's disease." The U.S. Senate, where Markey now serves, passed the legislation in July. ‘Alarming’: Severe obesity is climbing in the US. See who is most affected "Since my mother was diagnosed with Alzheimer’s in 1985, I have fought to ensure the federal government has the funding, resources, and coordination necessary to find a cure for this disease," Markey said. "The National Alzheimer’s Plan Act and the Alzheimer’s Accountability Act have transformed our understanding of the disease and its risk factors for more than a decade. But our work is not yet done. Today’s extension of these bills until 2035 is a commitment from Congress that we will not stop fighting until Alzheimer’s is a disease only found in history books." The House vote was the last one needed for Congress to pass a reauthorization of the National Alzheimer’s Project Act (NAPA) through 2035 and to "modernize" federal law to reflect advances in the understanding of the disease, such as including a new focus on promoting healthy aging and reducing risk factors. The bill also includes changes meant to reduce health disparities for underserved communities, including Black, Brown and disabled communities that are at increased risk for Alzheimer's. Also en route to the president's desk is the so-called Alzheimer’s Accountability and Investment Act, which Markey authored with a handful of others to continue through 2035 the requirement that the National Institutes of Health submit an annual budget to Congress estimating the funding necessary to fully implement NAPA’s research goals. The senator's office said cancer and HIV/AIDS are the only other biomedical fields to have been subject to special budget development aimed at speeding discovery. Markey particularly thanked Sen. Susan Collins of Maine, one of four Republicans in the group of eight senators leading the Alzheimer's legislation. The other sponsors were U.S. Sens. Mark Warner (D-Virginia), Shelley Moore Capito (R-W. Virginia), Jerry Moran (R-Kansas), Bob Menendez (D-New Jersey), Lisa Murkowski (R-Alaska), and Debbie Stabenow (D-Michigan).